Health2 days ago
FDA Extends Review of Ascendis Pharma’s Dwarfism Treatment
The U.S. Food and Drug Administration (FDA) has officially extended the review period for the New Drug Application (NDA) concerning Ascendis Pharma’s treatment for children with...
